Cargando...
Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
Histone acetylation is a critical process in the regulation of chromatin structure and gene expression. Histone deacetylases (HDACs) remove the acetyl group, leading to chromatin condensation and transcriptional repression. HDAC inhibitors are considered a new class of anticancer agents and have bee...
Guardado en:
| Publicado en: | Acta Pharm Sin B |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4724696/ https://ncbi.nlm.nih.gov/pubmed/26904403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2015.11.002 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|